CORCEPT THERAPEUTICS INC (CORT)

Overview Price 3.08 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank 3 - HOLD Open Price $0.00 Previous Close $3.08 Daily Range $0.00 - $0.00 52-Week Range $2.51 - $5.07 Volume 0 Corcept Therapeutics Incorporated is a pharmaceutical company focused on developing drugs for treating severe psychiatric and neurological diseases. Corcept's lead product, CORLUX, is in Phase clinical trials for treating the psychotic features of PMD. The drug is administered orally to PMD patients once per day for seven days. CORLUX, a potent GR-II antagonist, appears to reduce the effects of the elevated and abnormal release patterns of cortisol seen in PMD. The company has also initiated a proof-of-concept study to evaluate the ability of CORLUX to mitigate weight gain associated with the use of olanzapine. Other Resources for CORT Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. Corcept Therapeutics Incorporated is a pharmaceutical company focused on developing drugs for treating severe psychiatric and neurological diseases. Corcept's lead product, CORLUX, is in Phase clinical trials for treating the psychotic features of PMD. The drug is administered orally to PMD patients once per day for seven days. CORLUX, a potent GR-II antagonist, appears to reduce the effects of the elevated and abnormal release patterns of cortisol seen in PMD. The company has also initiated a proof-of-concept study to evaluate the ability of CORLUX to mitigate weight gain associated with the use of olanzapine.   Brokerage Analyst Recommendations 7 Brokerage Firms Covering CORT   Strong Buy 7 Buy 0 Hold 0 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1   CORT Ratings: BUY  SELL  HOLD CORT Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 4 Buy 1 Sell   Top Buy Analysis No Buy Analysis. Be the First. More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	06/27/11	Buffett Closes Wesco Deal - Analyst Blog	0
Zacks_Analysts	0.00	06/24/11	Berkshire Cuts Wesco Offer - Analyst Blog	0
Zacks_Analysts	0.00	09/02/10	Buffett Bids $500M for Wesco Stake - Analyst Blog	0
Zacks_Analysts	0.00	08/27/10	Buffett Gets 20% of Munger's Wesco - Analyst Blog	0
Zacks_Analysts	0.00	03/26/10	Corcept Posts Narrower Loss - Analyst Blog	0

Commentary

SELL: CORCEPT THERAPEUTICS INCORPORATED (CORT) Start Price: $3.25 Points: +7.01 Created: 02/01/2012 Needed 3.58+ ann 3.67 is already showing as a CT. 3J Comments: 0 | Comment JoeJustJoe Recs:

BUY: CORCEPT THERAPEUTICS INCORPORATED (CORT) Start Price: $3.82 Points: -22.38 Created: 07/14/2011 Comments: 0 | Comment ANTISEPTIC Recs:

BUY: CORCEPT THERAPEUTICS INCORPORATED (CORT) Start Price: $1.64 Points: +96.34 Created: 01/01/2008 Comments: 0 | Comment Veenu Recs:

BUY: CORCEPT THERAPEUTICS INCORPORATED (CORT) Start Price: $1.66 Points: +94.07 Created: 01/01/2008 Comments: 0 | Comment Trader2day Recs:

BUY: CORCEPT THERAPEUTICS INCORPORATED (CORT) Start Price: $3.19 Points: +4.79 Created: 01/01/2008 Comments: 0 | Comment BullRUSH Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
JoeJustJoe	99.58	SELL	Six Months to a Year	02/01/2012	$3.25	$3.09 (-6.08%)	-4.92%	+2.08%	+7.01	view close
ANTISEPTIC	2.54	BUY	One to Three Months	07/14/2011	$3.82	$3.09 (-6.08%)	-19.11%	+3.27%	-22.38
Veenu	78.22	BUY	Six Months to a Year	01/01/2008	$1.64	$3.09 (-6.08%)	+88.41%	-7.92%	+96.34
Trader2day		BUY	Six Months to a Year	01/01/2008	$1.66	$3.09 (-6.08%)	+86.14%	-7.92%	+94.07
BullRUSH		BUY	Six Months to a Year	01/01/2008	$3.19	$3.09 (-6.08%)	-3.13%	-7.92%	+4.79